• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

New BHF research in Leicester could improve diagnosis of the cause of heart failure

Aug 8, 2018

Researchers at the NIHR Leicester Biomedical Research Centre have been awarded a £158,000 project grant from the nation’s biggest heart charity to compare the accuracy of two different diagnostic tests that are normally used to help detect causes of heart failure.

Heart failure is a long-term condition that occurs when the heart is unable to pump blood around the body as effectively as it should.

In Leicester alone, there are nearly 3,000 people living with heart failure. Its main symptoms include shortness of breath and feeling unusually tired or weak. Patients are also likely to develop swollen feet, ankles and stomach, along with swelling around the lower back area. For people with severe heart failure, everyday tasks like going upstairs or walking to the shops become impossible.

To detect the causes of heart failure, patients can undergo a cardiac MRI ‘stress’ test. Two drugs – adenosine and dobutamine – can be used to ‘stress’ the heart. Either drug can be injected into patients to increase the workload of the heart, allowing doctors to better assess blood flow to the heart and see which parts of the heart muscle are not receiving an adequate blood supply.

However, it is unclear which of these drugs is the most accurate for detecting narrowed arteries, which reduce blood flow to the heart, and researchers at Leicester suspect that some patients with heart failure have a reduced sensitivity to adenosine. This could potentially lead to missed or wrongful diagnosis.

The two-year study will compare the two drugs in 100 patients with heart failure to find out which provides the most accurate diagnosis in cardiac MRI stress testing. The research, thought to be the first of its kind in people with heart failure, will be led by Professor Gerry McCann at the University of Leicester BHF Cardiovascular Research Centre based at Leicester’s Hospitals.

Professor Gerry McCann, Professor of Cardiac Imaging at the University of Leicester and Consultant Cardiologist at Leicester’s Hospitals, said: “MRI scanning is the best way to determine the cause of heart failure, as it allows us to take highly sophisticated images of the beating heart and examine it in much greater detail. It also presents us with a safe and accurate way to diagnose if coronary heart disease is the likely underlying cause.

“However, we don’t know which medicine allows us to best look at the blood supply to the heart during the MRI scan. This research will help us to understand which drug is the most effective, and could help us to prevent missed or wrongful diagnoses which would directly affect the care given.”

Dr Lucie Duluc, Research Advisor at the BHF, added: “Heart failure is a chronic condition that affects over half a million people in the UK. It currently has no cure and claims thousands of lives each year.

“Funding this new research at the University of Leicester could improve the diagnosis of the underlying causes of heart failure. This will allow people to receive the best treatments in order to live full and active lives.

“This funding has only been made possible by the fantastic generosity of the public. We rely on their support to drive forward research programmes in our mission to beat heartbreak forever and ensure that we keep hearts beating and blood flowing.”

VIDEO

A short video explaining the research and showing images of cardiac MRI stress testing can be downloaded by following this link: https://wetransfer.com/downloads/28610050c8fdd28b1c497808ca2e82b720180803073122/45a943.

If you require any original video files of the cardiac MRI stress testing without annotations, then please email kettlel@bhf.org.uk

Ends

 

 

Category: Press ReleasesTag: Press Release

Recent News

Leicester health specialists receive NIHR prizes for excelling in their fields

Respiratory researcher awarded Asthma + Lung UK Junior Fellowship

Weight-loss drug users turn to social media over doctors for advice

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}